GRIFOLS reported EUR20.28B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Alcon AG USD 31.37B 270M Sep/2026
Almirall EUR 2.37B 29.97M Jun/2026
Amadeus IT EUR 11.79B 30.7M Sep/2026
Amarin USD 634.08M 9.72M Sep/2026
argenx SE USD 10.03B 1.35B Jun/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Cie Automotive EUR 5.68B 97.53M Dec/2025
Demant DKK 40.03B 951M Jun/2026
Ence Energia y Celulosa EUR 1.67B 22.2M Sep/2026
Essilor EUR 65.06B 1.16B Jun/2026
Ferrovial EUR 27.22B 201M Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
Genmab DKK 12.52B 139M Jun/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Inditex EUR 36.61B 125M Jun/2026
Lakefront Biotherapeutics EUR 3.29B 56.62M Sep/2026
Merck EUR 53.66B 975M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Philips EUR 28.03B 1.33B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Smith & Nephew USD 11.01B 321M Jun/2026
UCB EUR 18.16B 971M Dec/2025
Viscofan EUR 1.54B 15.43M Sep/2026